The U.S. Food and Drug Administration has approved Litfulo (ritlecitinib) for adults and adolescents aged 12 years and older with severe alopecia areata at a recommended dose of 50 mg. Approval of Litfulo was granted to Pfizer.
Jun 27, 2023
0
1
Research conducted at University of Nevada, Reno and licensed through the University's Technology Transfer Office is featured in the technology transfer publication "Better World Report" for a remarkable second year in a ...
Dec 3, 2011
0
0
The Food and Drug Administration has approved a new test to help physicians diagnose a group of rare cell disorders. The test, or assay, was developed by an expert at Virginia Commonwealth University in the field of mast ...
May 22, 2012
0
0
A new drug called perampanel appears to significantly reduce seizures in people with hard-to-control epilepsy, according to results of the first clinical trial to test the higher 12 mg dose of the drug. The late-breaking ...
Apr 13, 2011
0
0
Peptides that mimic the function of HDL cholesterol, which has been dubbed "good cholesterol," can treat the underlying inflammation associated with inflammatory bowel disease, or IBD, according to new research in mice. The ...
Jun 12, 2019
0
2
Being able to recapitulate in a dish what human embryos normally do hidden within the womb opens avenues for improving In Vitro Fertilization (IVF) procedures and developing better contraceptives. Hormonal contraceptives ...
Dec 2, 2021
0
69
Based on the findings of a new study led by the Translational Genomics Research Institute (TGen), part of City of Hope, a coast-to-coast clinical trial is planned that, if successful, could lead to FDA approval of the first ...
May 3, 2022
0
70
(HealthDay)—After infections tied to unapproved stem cell treatments sent 12 people to hospital this past year, the U.S. Food and Drug Administration on Thursday issued a stern warning about the products.
Dec 21, 2018
0
5
There is good news for those suffering from spinal cord injuries. The U.S. Food and Drug Administration gave its stamp of approval to ReWalk—the exoskeleton that enables paraplegics to walk. While the device has sparked ...
Jul 2, 2014
0
1
Many consumers mistakenly believe new prescription drugs are always safer than those with long track records, and that only extremely effective drugs without major side effects win government approval, according to a new ...
Sep 12, 2011
0
0
